Need Regulatory Help? Try Our Platform
Post your regulatory questions or request quotations from verified pharmaceutical consultants worldwide. Get matched with experts who specialize in your market.
January 8, 2026
Approximately 5 minutes
Donation of Medicinal Products in Spain – AEMPS Regulatory Guidelines
Donation of Medicinal Products in Spain – AEMPS Regulatory Guidelines
Legal Framework
Donations of medicinal products in Spain are regulated under Directive 2001/83/EC (as amended), Royal Decree 782/2013 on wholesale distribution, and specific AEMPS guidance to ensure donated medicines meet the same quality, safety, and efficacy standards as those placed on the market. Donations are permitted only from authorised manufacturers, wholesalers, or pharmacies, and recipients must be qualified entities (e.g., healthcare facilities, NGOs with authorisation, or public health programmes). The framework aims to prevent falsified or substandard medicines while supporting humanitarian aid and access in resource-limited contexts. Donaciones de medicamentos - AEMPS
Eligible Donors and Recipients
- Donors: Must hold valid manufacturing or wholesale distribution authorisation from AEMPS or another competent authority (for EU/EEA donors).
- Recipients: Typically authorised healthcare institutions, non-profit organisations with health-related authorisation, or international humanitarian organisations. Private individuals cannot receive donations directly.
- Prohibited Donations: Controlled substances (narcotics, psychotropics), investigational medicinal products, expired medicines, or products without proper documentation.
Key Conditions for Donation
- Quality and Traceability: Donated medicines must be in original packaging, unopened (or properly resealed if samples), with at least 6 months remaining shelf life (exceptions possible with justification), and full batch traceability.
- Storage and Transport: Donors must ensure proper storage conditions (temperature, humidity) and use qualified transport meeting GDP standards.
- Documentation: Complete donation certificate including donor/recipient details, product list, batch numbers, expiry dates, quantity, and declaration of compliance with quality standards.
- No Financial Benefit: Donations must be free of charge; no commercial transaction or inducement allowed.
- Pharmacovigilance: Donors remain responsible for reporting any subsequent quality or safety issues related to donated products.
Special Cases
- Humanitarian Aid: Donations for international aid programmes may follow simplified procedures with prior AEMPS authorisation and coordination with the Spanish Agency for International Development Cooperation (AECID).
- Near-Expiry Donations: Possible under exceptional circumstances with risk assessment and recipient agreement.
- Veterinary Medicines: Separate rules apply, often aligned with similar principles.
Procedure and Authorisation
Donors must notify AEMPS in advance for large-scale or international donations and obtain specific authorisation when required (e.g., export of donated medicines). Recipients must confirm acceptance and proper use/intended purpose. AEMPS may inspect donation processes and require post-donation reports.
This regulated donation system balances the potential benefits of redistributing quality medicines with strict safeguards to protect public health. Detailed requirements, templates for donation certificates, application forms, and contact information are available on the AEMPS page dedicated to medicinal product donations. Donaciones de medicamentos - AEMPS
Ask Anything
We'll follow up with you personally.
Related Articles
Approximately 5 minutes
Foreign Trade of Medicinal Products in Spain – AEMPS Regulatory Framework
AEMPS oversees foreign trade of medicinal products in Spain, regulating imports, exports, parallel distribution, and transit operations to ensure compliance with EU standards, quality requirements, and safety features while facilitating legitimate international movement of authorised medicines.
Approximately 5 minutes
Recommendations for Medicinal Product Distributors on Sales Practices – AEMPS Guidelines
AEMPS provides key recommendations to wholesale distributors in Spain to promote ethical, transparent, and compliant sales practices, emphasizing proper customer verification, avoidance of aggressive promotion, documentation of transactions, and prevention of diversion or falsified medicines in the legitimate supply chain.
Approximately 5 minutes
Instructions for Reporting Suspected Illicit Traffic of Medicinal Products – AEMPS Guidance
AEMPS provides detailed instructions to authorised pharmaceutical distributors in Spain on how to identify, document, and promptly report suspected cases of illicit trafficking, diversion, or falsified medicines to safeguard the legitimate supply chain and support enforcement against pharmaceutical crime.